Literature DB >> 12626035

Effects of sex steroid hormones and menopause on serum leptin concentrations.

C Di Carlo1, G A Tommaselli, C Nappi.   

Abstract

Leptin is a protein secreted by adipocytes; its circulating levels are correlated to fat mass and it acts on the hypothalamic centers regulating body weight. Leptin may also play an important role in regulating reproductive function. Indeed, ob/ob mice, lacking leptin due to a genetic mutation, are obese and infertile; administration of recombinant leptin to these animals reduces body weight and restores fertility. A sexual dimorphism in serum leptin levels has also been observed, with higher concentrations in women. Studies in vitro seem to indicate that estrogens stimulate leptin secretion, while in vivo studies are extremely discordant. In humans, several studies showed increased, unmodified and decreased leptin levels after the menopause. Furthermore, hormonal replacement therapy (HRT) after the menopause was reported to result in unmodified, increased or decreased leptin levels. It is likely that the effects of postmenopausal hypoestrogenism on leptin levels are masked by the postmenopausal changes in body composition. Indeed, after menopause, there is an increase in body weight, body mass index (BMI) and fat mass with a centralization of fat distribution. Administration of HRT may stop these changes and even restore a premenopausal pattern, leading then to decreased leptin levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12626035

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

1.  Rapid decrease of leptin in middle-aged sedentary individuals after 20 minutes of vigorous exercise with early recovery after the termination of the test.

Authors:  I N Legakis; T Mantzouridis; A Saramantis; E Lakka-Papadodima
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

2.  Leptin levels do not change following acute exercise in healthy adults and in obese children.

Authors:  A Sartorio; F Agosti; A De Col; P G Marinone; N A Maffiuletti
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

3.  Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women.

Authors:  Amy C Soni; Molly B Conroy; Rachel H Mackey; Lewis H Kuller
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

Review 4.  Leptin in the interplay of inflammation, metabolism and immune system disorders.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Jesús Pino; Miguel Angel Gonzalez-Gay; Juan J Gómez-Reino; Antonio Mera; Francisca Lago; Rodolfo Gómez; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

5.  Hypothalamic NPY-Y1R Interacts with Gonadal Hormones in Protecting Female Mice against Obesity and Neuroinflammation.

Authors:  Alessandra Oberto; Ilaria Bertocchi; Angela Longo; Sara Bonzano; Silvia Paterlini; Clara Meda; Sara Della Torre; Paola Palanza; Adriana Maggi; Carola Eva
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

6.  Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study.

Authors:  Anne Stuedal; Giske Ursin; Marit B Veierød; Yngve Bremnes; Janne E Reseland; Christian A Drevon; Inger T Gram
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

7.  Higher hemoglobin levels are an independent risk factor for adverse metabolism and higher mortality in a 20-year follow-up.

Authors:  Joona Tapio; Hannu Vähänikkilä; Y Antero Kesäniemi; Olavi Ukkola; Peppi Koivunen
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

8.  Leptin levels and nutritional status of indigenous Tepehuán and Mestizo subjects in Durango, Mexico.

Authors:  Dealmy Delgadillo Guzmán; Laurence Annie Marchat Marchau; José L Reyes; Verónica Loera Castañeda; Martha Sosa Macías; Jessica García Vivas; Ismael Lares Asseff
Journal:  Dis Markers       Date:  2014-04-14       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.